High-dose budesonide for early COVID-19 - Authors' reply. (2021)
Attributed to:
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)02449-1
PubMed Identifier: 34895528
Publication URI: http://europepmc.org/abstract/MED/34895528
Type: Journal Article/Review
Volume: 398
Parent Publication: Lancet (London, England)
Issue: 10317
ISSN: 0140-6736